The primary mission of the Research & Development (R&D) division of the Stago Group is to design products and solutions (automatic analysers, reagents, consumables, services, etc.) that meet the needs of biologists and clinicians, with the goal of improving treatment for clotting disorders and thrombosis. Working alongside the scientific community, R&D also focuses on identifying and studying new markers and methods for exploration in these areas.
Since 1962, the Stago Group has concentrated its attention on biology, specialising in the "emerging" sector of haemostasis. Thanks to this clear focus, the group is now recognised worldwide by the scientific community in this field. Stago continues to maintain and develop strong links with the haemostasis community on a day-to-day basis by: